Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-24-003922
Accepted
2024-12-27 00:15:02
Documents
1
Effectiveness Date
2024-12-26

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 603
  Complete submission text file 9999999995-24-003922.txt   2048
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-283949 | Film No.: 241582126
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)